SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-011130
Filing Date
2021-05-06
Accepted
2021-05-06 16:00:58
Documents
47
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q govx20210331_10q.htm 10-Q 344677
2 EXHIBIT 31.1 ex_245663.htm EX-31.1 12971
3 EXHIBIT 31.2 ex_245664.htm EX-31.2 13039
4 EXHIBIT 32.1 ex_245665.htm EX-32.1 5436
5 EXHIBIT 32.2 ex_245666.htm EX-32.2 5243
  Complete submission text file 0001437749-21-011130.txt   1874749

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT govx-20210331.xml EX-101.INS 185914
7 XBRL TAXONOMY EXTENSION SCHEMA govx-20210331.xsd EX-101.SCH 28108
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE govx-20210331_cal.xml EX-101.CAL 23370
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20210331_def.xml EX-101.DEF 188164
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20210331_lab.xml EX-101.LAB 164942
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20210331_pre.xml EX-101.PRE 203226
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39563 | Film No.: 21897558
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences